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Results
Effect of AM supernatants on the proliferation of fibroblasts: The basic proliferation rate of Fb from SA and HP patients was shown to be significantly lower than that of Fb in the CO group (Table 2) .
AM-derived supernatants were tested for effects on the proliferation of Fb in an autologous culture set-up and in presence of AM supematant of CO patients ( Fig. 1) and on normal Fb lines (Fig. 2) . The AM supernatants of SA and HP suppressed the prolifera- (Fig. 3a, b, c and d (Fig. 4a and   b ). These concentrations include the range of IL-113 by AM of SA and HP patients (4-0.8 ng/ml). As a general trend in Fbs of the CO group, no suppressive activity was observed at minute concentrations of ILl[3 (Fig. 4c) . The modulatory effects of IL-13 were abrogated by anti-IL-1 antibodies or indomethacin ( Table 6 ). A clear reversion of the suppression was achieved in the SA and HP group, but not in the CO and DIF groups.
Discussion AM are present within the alveoli and bronchioli while the fibrosis occurs in the interstitium. However, it is feasible to assume that AM affect the process of fibrosis because of their close proximity. The outcome of a number of interstitial lung diseases (ILD) results in severe pulmonary fibrosis. In contrast, patients with SA or HP, manifesting inflammatory or granulomatous diseases, usually heal without excessive scarring. In the present study, we assessed the fibroblast-macrophage interactions in ILD, in an attempt to understand the differential outcome of the diseases. We assessed the proliferative capacity of Fb and the secretion of cytokines/inflammatory products by AM and Fb, the latter being the target cells in these diseases.
We showed ( 4 or increased 25 cytokine production by fibroblasts in chronic GVHD (graft versus host dis- Fibroblast proliferation in ILD Our results indicate that IL-I[, at the levels equivalent to those present in the microenvironment in the lungs of SA and HP patients (0-4 ng/ml), exerts a suppressive effect on slowly subconfluent proliferating alveolar Fb from these diseases, whereas at levels detected in normal lungs (0-0.2 ng/ml), enhance the replication of actively proliferating Fb recovered from control lungs (Fig. 3a-c 
